Products In Endoscope Articles & Analysis: Older
41 news found
Data demonstrate favorable safety and efficacy profile for the duodenal jejunal bypass liner (DJBL) technology BOSTON — July 13, 2022 — GI Dynamics® Inc., a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce positive data from the Association of British Clinical Diabetologists (ABCD) Worldwide ...
Initial results show the duodenal jejunal bypass liner (DJBL) technology met overall glycemic control efficacy and SAE related device removal safety endpoints Findings Presented at DDW 2022 BOSTON – June 15, 2022 – GI Dynamics, a medical device company that is developing the EndoBarrier® System for patients diagnosed with type 2 diabetes and obesity, announced results from a ...
This new platform is designed to deliver improved operating room productivity, patient safety, and economic value through cost savings, energy efficiency, and reduced setup/breakdown times. ...
EvoEndo, Inc. (“EvoEndo”), a medical device company which developed a single use system that allows for unsedated Transnasal Endoscopy (TNE), has announced the completion of an $8.4 million Series A financing round led by founding investor TLP Investment Partners LLC (TLP) and including the Sunshine Charitable Foundation and the Jill and Paul Meister family. Proceeds from the ...
ByEvoEndo
A new biopsy sheath developed by Raleigh med tech startup UVision360 is ready to hit the market after landing federal approval this week. UVision360 announced it had received the greenlight from the U.S. Food and Drug Administration for its patented LUMINELLE 360° Bx Sheath. The device expands the startup’s “all-in-one” gynecological system LUMINELLE DTx, an endoscopic ...
Sanford, Florida (February 21, 2022) — Omega Medical Imaging, the leading innovator in AI image-guided interventional systems for hospitals and healthcare facilities around the world, announced the installation of E-View.AI interventional endoscopy systems at Orlando Health. Located in downtown Orlando, the Orlando Health Digestive Health Institute is a national and international ...
About EvoEndo EvoEndo, Inc. is a medical device company developing systems that enable unsedated endoscopic procedures through a combination of sterile single-use, flexible endoscopes and VR-based patient distraction. ...
ByEvoEndo
The ArthroFree system is designed to deliver improved operating room productivity, patient safety, and economic value through cost-savings, energy efficiency, and reduced setup/breakdown times. ...
Ronald Wassenburg, CEO Wassenburg Medical B.V.: “This acquisition is an opportunity for Custom Ultrasonics to expand their product portfolio with our products. For us, it is a window to the US market. ...
“Our ArthroFree system provides wireless visualization for endoscopic instruments with a plug-and-play receiver that is compatible with virtually all existing patient data consoles and a handpiece that is compatible with all C-mount scopes. ...
About EvoEndo EvoEndo, Inc. is an early-stage medical device company developing systems that enable unsedated endoscopic procedures through a combination of sterile single-use, flexible endoscopes and VR-based patient entertainment. ...
ByEvoEndo
Sanford, Florida (July 28, 2021) — Omega Medical Imaging, the leading innovator in AI image-guided interventional systems for hospitals and healthcare facilities around the world, announced the installation of the E-View.AI interventional endoscopy system at the Pali Momi Medical Center in Hawai’i. The E-View.AI represents the first AI image-guided system in the state of ...
UVision360, Inc., an innovative medical device company, announces today that the U.S. Food and Drug Administration (FDA) has approved the Company's expanded reprocessing procedures for use with the LUMINELLE DTx System. This expansion will allow the LUMINELLE DTx System to be more fully utilized in broader settings such as Hospital Systems and Outpatient Surgical Centers. It will also support ...
UVision360, Inc., an innovative medical device company, announces today that the U.S. Food and Drug Administration (FDA) has approved the patented LUMINELLE 360° Bx (Biopsy) Sheath which expands the capability of the LUMINELLE® DTx System. The LUMINELLE 360° Bx sheath, combined with the LUMINELLE DTx System, is the first and only integrated directed biopsy device not requiring ...
Relying on the world's leading technology and strong sustainable R&D strength, and with the support from investment institutions and the continuous attention from our peers, Scivita Medical will form a platform with a comprehensive layout of innovative products in endoscope and related fields. It is committed to using domestic high-quality innovative ...
UVision360, Inc., an innovative FemTech company, announces today that the U.S. Food and Drug Administration (FDA) has accepted the Company's submission for expanded reprocessing procedures for use with the LUMINELLE DTx Hysteroscopy System. Supported by STERIS® Device Testing procedures, UVision360, Inc. is adding the Revital-Ox® RESERT® HLD as a high-level disinfectant method and ...
UVision360, Inc., an innovative FemTech company, announces today that the United States Patent and Trademark Office has issued a system method patent, No.10926059, for the Company's LUMINELLE® DTx System (LUMINELLE). The new patent allows UVision360 to protect the method of assembly and manufacturing of the LUMINELLE system and sheaths with a rotatable function and includes a variety of ...
January 13, 2021 (Press Release) – PLANO, Texas. AnX Robotica Corporation, (www.anxrobotics.com), the developer and manufacturer of the NaviCam Magnetically Controlled Capsule Endoscopy (MCCE) System, is pleased to announce that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT) code for Magnetically controlled capsule endoscopy, which can help ...
Over time, doctors developed less invasive techniques including a way to expand and clear the nasal passages endoscopically. But the devices were costly (around $2,000) and single-use only. ...
“His unique set of skills allows us to both pursue the regulatory approvals the company requires, while at the same time preparing for commercialization of this valuable product in the fight against type 2 diabetes and obesity. We are fortunate to have attracted a gentleman of such high caliber during the COVID-19 ...